Viral S protein-mediated ACE2 dysregulation in cardiac cells triggered NLRP3 inflammasome activation and proinflammatory cytokine response, hence aggravating cardiovascular disease comorbidity in COVID-19 (186). This evidence concerns the gene ACE2 and COVID-19.